Granules India Limited (GRANULES) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE101D01020
Key metrics
- Market Cap
- ₹20,611 Cr
- P/E Ratio
- 31.06
- EPS
- 26.78
- Book Value
- 205.21
- P/B Ratio
- 4.06
- ROE
- 11.7%
- ROCE
- 13.65%
- Debt / Equity
- 0.3
- Net Margin
- 11.14%
- Revenue Growth
- 19.81%
- Profit Growth
- 18.64%
- Dividend Yield
- 0.21%
- 52W High
- ₹910.00
- 52W Low
- ₹507.30
- Market Cap Band
- large cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Granules India Limited
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally. It offers paracetamol, metformin, guaifenesin, ibuprofen, and methocarbamol, as well as prescription and over-the-counter products. The company also develops and manufactures tablets, capsules, press fits, oral solutions, suspensions, and powder for oral solutions. In addition, it provides development and manufacturing solutions for peptides, peptide fragments, and amino acid derivatives. The company offers its products in various therapeutic categories, including antiretroviral, anti-depressant, antihistamine, anti-diabetic, anti-cancer, multiple sclerosis, anti-thrombocytopenia, anti-ulcer, anti-convulsant, mucolytic/expectorant, anti-hypertensive, muscle relaxant, NSAIDs, anti-fibrotic, and anti-microbial, as well as anti-arrhythmic, CNS stimulant, anti-diarrheal, antihypertensive, uterine stimulant, chelating agent, mineral supplements, CNS depressant, PDE inhibitor, antispasmodic, and anti-viral. Granules India Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Employees
- 4,306
- Promoter Holding
- 39.31%
The full Granules India Limited analysis
Create a free account to open the complete GRANULES deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.